GHRH analog raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-02-15 and is reviewed periodically as new material appears.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
=== Early days of Pentagram === Though Pentagram struggled with lineup changes and financial issues, the band became a key influence in the development of doom metal, with Liebling's distinct vocals and songwriting playing a major role in their cult following. Their early recordings, particularly Relentless (1985) and Day of Reckoning (1987), laid the groundwork for future doom metal acts. Despite their potential, Liebling's struggles with substance abuse, internal conflicts, and frequent lineup changes prevented Pentagram from achieving stability and mainstream success. By the mid-1970s, the band had caught the attention of influential managers and producers. One such figure was Gordon Fletcher, a columnist for Rolling Stone and Creem, who connected them with Sandy Pearlman and Murray Krugman, producers and managers of Blue Öyster Cult. Pentagram had an opportunity to record a full album, but the deal collapsed when Liebling, dissatisfied with the production of one of his tracks, had a heated argument with Krugman. As a result, Krugman walked out, canceling their contract. Gene Simmons and Paul Stanley of Kiss were invited to a Pentagram rehearsal, with hopes of impressing them and securing their mentorship. However, guitarist Vince McAllister and bassist Greg Mayne, who at the time were janitors, arrived late, still in their dirty uniforms from work. The Kiss members mocked their appearance rather than taking the band seriously. Despite this, Paul Stanley offered to purchase some of their songs, but Liebling refused, wanting to keep control of his material.
=== Genetics === Habitat fragmentation has been shown to have minimal effect on the genetic diversity and gene flow of the North American woodland violet Viola pubescens. This may be partially attributed to the ability of Viola pubescens to continue to persist within a largely agricultural matrix. This trend of unexpectedly high genetic diversity is also observed in Viola palmensis, a Canary Island endemic known only from a 15 square kilometer range on La Palma island. High levels of genetic diversity within these species indicate that these plants are outcrossing, even though many violet species can produce many clonal offspring throughout the year via cleistogamous flowers. Plants that produce copious amounts of clonal seeds from cleistogamous flowers often experience increased levels of inbreeding. These reportedly high rates of outcrossing and genetic diversity indicate that these violets are strong competitors for pollinators during the early spring when they are in bloom and that those pollinators can travel considerable distances between often fragmented populations.
Kamiyah as well as all the patients found through the column became the breakthrough needed to begin proper human research towards a diagnosis and treatment of the gene mutation. While Kamiyah was not able to technically receive a diagnosis for her illness, she created the pathway for research into possible treatments for patients in the future.
Sources: en.wikipedia.org
Subsequent clinical studies have supported the effectiveness and stability of CAIRS across various forms of corneal ectasia, with promising results maintained for up to five years. Dr Jacob also holds patents for specialised trephination and implantation instruments, further standardising and refining the procedure. The high degree of customisation available with CAIRS keratoplasty is one of its greatest clinical advantages, enabling surgeons to tailor treatment to the patient's specific topography and visual needs. Some commercial providers have introduced branded versions of pre-prepared donor segments, such as "CTAK". While the branding differs, these procedures are still CAIRS keratoplasty; the trademarked names apply only to the tissue supply or preparation system rather than the surgical concept itself. To support surgeons in planning CAIRS procedures, Dr Brendan Cronin and Dr David Gunn, keratoconus specialists based in Brisbane, Australia, have developed a free web-based planning resource: www.cairsplan.com. This platform provides guidance and planning tools to help optimize surgical outcomes and expand access to this innovative approach.
Mark Stoyer, a nuclear chemist at the LLNL, later recalled, "We had intended to propose that name from Livermore, and things kind of got proposed at the same time from multiple places. I don't know if we can claim that we actually proposed the name, but we had intended it." In internal discussions, IUPAC asked the JINR if they wanted the element to be spelled "oganeson" to match the Russian spelling more closely. Oganessian and the JINR refused this offer, citing the Soviet-era practice of transliterating names into the Latin alphabet under the rules of the French language ("Oganessian" is such a transliteration) and arguing that "oganesson" would be easier to link to the person. In June 2016, IUPAC announced that the discoverers planned to give the element the name oganesson (symbol: Og). The name became official on 28 November 2016. In 2017, Oganessian commented on the naming:
== Safety Profile == Amarasate has been well tolerated in human trials, with no serious adverse events reported. Mild gastrointestinal symptoms such as bloating or nausea have occasionally been observed, typically resolving without intervention. The extract is derived from a food source (hops) traditionally used in brewing and is generally recognized as safe (GRAS) by the FDA for use in dietary supplements.
=== Commonwealth period === From 1914 to 1927, parts of Western Negros hosted several newly established settlements which became cities connected by railroads constructed to flow towards several "sugar centrals" which were processing the extremely sweet raw sugar canes grown in Negros' volcanic soil and farmed by several "Haciendas". These haciendas littered the countryside as the central sugar mills eventually grew to become full pledged towns and cities: chief among which were Ilog, Hinigaran, La Carlota, Silay, Pulupandan, Bacolod, San Carlos and Bais. Western Negros also saw massive immigration from Panay as the Spanish, Chinese, and French mestizos, plus others, who were serving in the Haciendas imported laborers from Panay island to foster the farming of Negros' sugar plantations and thereby displacing the Cebuano speaking natives. Soon, vast numbers of immigrants from Spain, most of them Basques, became Negros' plantation owners. The east side of Negros was not as thickly settled but became a center of education as on 9 April 1901, the Second Philippine Commission under the chairmanship of William H. Taft arrived in Dumaguete. Weeks later on 1 May, the civil government under American sovereignty was established, and on 28 August, Dr. David S. Hibbard founded what is now Silliman University the first American school in the Philippines and the entire Asian continent with the help of Meliton Larena as the first Mayor of Dumaguete, as well as Demetrio Larena.
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.